glp 1 agonists and depression Frontiers GLP-1 medications used to treat
Description
393 As a result, GLP-1RAs could mitigate the detrimental effects of hyperlipidemia-induced skeletal defects, leading to an improved prognosis in individuals with OA
doi: 10.1016/J.EBIOM.2024.105284 105 Izzi-EngbeayaCJonesSCrustnaYMachenahalliPCPapadopoulouDModiMet al
A completely different approach was employed by He et al
Recent studies using GLP1R/GIPR dual agonists, especially the SURPASS clinical trials, have revealed beneficial effects of GIP activation when used in conjunction with GLP-1RAs
Physiology of GIPa lesson from GIP receptor knockout mice
Self-determination theory and physical activity: The dynamics of motivation in development and wellness
